Company
Viiv Healthcare Overseas Limited
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Viiv Healthcare Overseas Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 11
- Neil Richard Wilkinson 2023-2024 View profile
- Cheryl Faye Macdiarmid 2019-2024 View profile
- Jill Dawn Anderson 2018-2023 View profile
- Gregory Maxime Reinaud 2017-2019 View profile
- Neil Peter Shortman 2015-2017 View profile
- Mark Robert Dawson 2015-2017 View profile
- Jerome Charles Maurice Andries 2013-2017 View profile
- Subesh Ronald Williams 2009-2013 View profile
- Dominique Jean Marc Limet 2009-2017 View profile
- Terry Lynn Crandall 2009-2017 View profile
- Victoria Anne Whyte 2009-2009 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 23/09/2009
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Viiv Healthcare Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Group
- Viiv Healthcare Overseas Limited
is controlled by Viiv Healthcare Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Viiv Healthcare Limited
is controlled by Glaxosmithkline Mercury Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2017-04-06 · source: Companies House PSC register - Glaxosmithkline Mercury Limited
is controlled by GSK PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by GSK PLC.
86 other companies in this group
- Smithkline Beecham Legacy H Limited
- Smithkline Beecham Overseas Limited
- GSK LP Limited
- Setfirst Holdings Limited
- Stevenage Bioscience Catalyst
- Glaxo Laboratories Limited
- Smithkline Beecham Senior Executive Pension Plan Trustee Limited
- Glaxosmithkline IHC Limited
- Smithkline Beecham Marketing and Technical Services Limited
- Stiefel Laboratories (Maidenhead) Limited
- Action Potential Venture Capital Limited
- Viiv Healthcare Finance Limited
- Charles Midgley Limited
- GSK Finance (NO 2) Limited
- Glaxosmithkline Caribbean Limited
- Burroughs Wellcome International Limited
- Smithkline Beecham Pension Trustees Limited
- Stiefel Laboratories Limited
- Glaxosmithkline Mercury Limited
- Setfirst Limited
- Dealcyber Limited
- GSK Finance (NO.3) Limited
- Viiv Healthcare UK (NO.5) Limited
- Viiv Healthcare Finance 2 Limited
- Wellcome Consumer Healthcare Limited
- Glaxo Wellcome UK Limited
- Glaxosmithkline Intellectual Property Management Limited
- Glaxosmithkline Intellectual Property Limited
- Mixis Genetics Limited
- Glaxo Group Limited
- Allen & Hanburys Limited
- Glaxosmithkline Intellectual Property Holdings Limited
- Smithkline Beecham (Export) Limited
- Glaxosmithkline Intellectual Property Development Limited
- Viiv Healthcare Trading Services UK Limited
- Viiv Healthcare Finance 1 Limited
- Clarges Pharmaceuticals Limited
- Glaxo Trustees Limited
- Glaxosmithkline International Limited
- Glaxochem (UK) Unlimited
- Viiv Healthcare Limited
- Tres Cantos Open LAB Foundation
- Viiv Healthcare UK (NO.3) Limited
- Glaxosmithkline Intellectual Property (NO.5) Limited
- Eskaylab Limited
- Glaxosmithkline Intellectual Property (NO.2) Limited
- Viiv Healthcare UK (NO.4) Limited
- Cellzome Limited
- Smithkline Beecham (SWG) Limited
- Smith Kline & French Laboratories Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Robert Bowers Director · appointed 2024
- Deborah Jayne Waterhouse Director · appointed 2017
- Rebecca Elizabeth Hall Director · appointed 2024
- Karen Marion Grainger Director · appointed 2017
Directors past 6 years
- Deborah Jayne Waterhouse Director · appointed 2017
- Karen Marion Grainger Director · appointed 2017
First-time vs portfolio directors
Portfolio (4)
- Robert Bowers Director · appointed 2024
- Deborah Jayne Waterhouse Director · appointed 2017
- Rebecca Elizabeth Hall Director · appointed 2024
- Karen Marion Grainger Director · appointed 2017
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
Where to look Suggested search: succession planning for long-tenured seats.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 07027385
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data